Skip to main content

Voyager Acquisition Corp.

corporate_fare Company Profile

Voyager Acquisition Corp.

VACH·NASDAQ·Life Sciences·CIK 0002006815

Voyager Acquisition Corp. is a blank check company, incorporated in the Cayman Islands on December 19, 2023. The company's purpose is to complete an initial business combination, such as a merger, share exchange, asset acquisition, share purchase, or reorganization, with one or more businesses or entities. On August 12, 2024, Voyager Acquisition Corp. completed its initial public offering (IPO) by selling 25,300,000 units, which included 3,300,000 units from the underwriters' over-allotment option. Each unit was priced at $10.00, resulting in gross proceeds of $253,000,000 for the company. Each unit consists of one Class A ordinary share, with a par value of $0.0001 per share, and one-half of one redeemable warrant. Each whole warrant allows the holder to purchase one Class A ordinary share for $11.50 per share. While the company may pursue acquisitions in any business, industry, sector, or geographical location, it intends to focus on the healthcare or healthcare-related industries. The company has not generated any operating revenues to date and does not anticipate generating operating revenues until it completes its initial business combination.

Voyager Acquisition Corp. (NASDAQ:VACH) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 10 items for VACH at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-05-29, rated 9/10. Across its 10 most recent items scored 7 or higher, the top rating is 9/10, with 9 rated 8 or above. Recent SEC coverage for VACH spans 8-K, 10-Q.

Recent high-impact activity:

  • Voyager Acquisition Secures $27.5M in Secured Notes, $50M Equity Facility to Address Liquidity Crisis
  • Voyager Acquisition Secures $29.56M in Secured Notes & Warrants, Establishes $50M ATM Program Amid Liquidity Crisis
  • Voyager Acquisition Corp. Issues Going Concern Warning Amidst Near-Total Share Redemptions
  • Shareholders Approve Veraxa Biotech Merger Amidst 99.67% Share Redemptions
  • Voyager Acquisition Secures Final Approval for Veraxa Biotech Merger

Financial Snapshot

Fiscal year ended December 31, 2025
Net Income
$8.99M
Op. Cash Flow
-$486.18K
Operating Income
-$1.79M
Cash & Equivalents
$182.1K
Debt / Equity
0.00×
Source: 10-K · filed 2026-04-02 · accession 0001829126-26-003103

Dilution Risk

Low risk

Filing-implied dilution signals for VACH, detected from its recent SEC filings.

ATM program

Secured Private Placement · At-The-Market (ATM) Program Established

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with V →
$16 -1.30% today
52-week range · as of 2026-05-29 $8.4 – $16
Market cap
$541.25M
Volume
12.4K (1.2× avg)
3-mo avg 10.7K
Last traded · 2026-06-11

show_chartPrice Chart

Loading chart...

feed VACH - Latest Insights

VACH
May 29, 2026, 4:03 PM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $9.61
Real-time Price: $16.00 info
Change: +$6.39 (+66%) info
Market Cap: $541.252M info
VACH
May 29, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $9.61
Real-time Price: $16.00 info
Change: +$6.39 (+66%) info
Market Cap: $541.252M info
VACH
May 20, 2026, 5:03 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $11.01
Real-time Price: $16.00 info
Change: +$4.99 (+45%) info
Market Cap: $541.252M info
VACH
Mar 18, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $12.48
Real-time Price: $16.00 info
Change: +$3.52 (+28%) info
Market Cap: $541.252M info
VACH
Mar 13, 2026, 6:01 AM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $12.23
Real-time Price: $16.00 info
Change: +$3.77 (+31%) info
Market Cap: $541.252M info
VACH
Mar 11, 2026, 6:00 AM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $11.61
Real-time Price: $16.00 info
Change: +$4.39 (+38%) info
Market Cap: $541.252M info
VACH
Mar 10, 2026, 5:35 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $10.63
Real-time Price: $16.00 info
Change: +$5.37 (+51%) info
Market Cap: $541.252M info
VACH
Feb 27, 2026, 4:53 PM EST
Source: Unknown
Importance Score:
8
Price at Filing: $10.69
Real-time Price: $16.00 info
Change: +$5.31 (+50%) info
Market Cap: $541.252M info
VACH
Feb 27, 2026, 4:45 PM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $10.69
Real-time Price: $16.00 info
Change: +$5.31 (+50%) info
Market Cap: $541.252M info
VACH
Feb 03, 2026, 7:04 AM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $10.67
Real-time Price: $16.00 info
Change: +$5.33 (+50%) info
Market Cap: $541.252M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets